Further investigation of morphine 3-glucuronide's role in the dose-limiting excitatory side-effects of morphine administered chronically to cancer patients (1998-1999)
Experts
Emeritus Professor
Maree Smith
Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR)